Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;18(2):106-109.
doi: 10.1055/s-0039-1677805.

Rare Spontaneous Attenuation of Childhood Inflammatory Cerebral Adrenoleukodystrophy

Hyoung Won Choi  1 , Gerald Vincent Raymond  2 , Weston Miller  3
Affiliations

Rare Spontaneous Attenuation of Childhood Inflammatory Cerebral Adrenoleukodystrophy

Hyoung Won Choi et al. J Pediatr Neurol. 2020 Apr.

Abstract

X-linked adrenoleukodystrophy (ALD) is a neurodegenerative peroxisomal disorder with variable clinical phenotypes. Childhood cerebral ALD (CCALD) is at the most severe end of the disease spectrum. In CCALD, the clinical manifestations include increasing deficits in behavior, vision, hearing, coordination, and motor function, as well as seizures. Without treatment, CCALD often results in apparent vegetative state within 1 to 2 years of appearance of initial signs and symptoms. We present the case of a boy with classic inflammatory CCALD who exhibited spontaneous attenuation in disease progression. While extremely rare, spontaneous arrest of disease progression may occur in boys with inflammatory CCALD.

Keywords: cerebral adrenoleukodystrophy; inflammatory; spontaneous arrest.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Brain MRI at the age of 9 years. (A) T2-weighted image shows a symmetric and confluent demyelinating lesion within the parieto-occipital lobes. (B) T1-weighted image post gadolinium administration demonstrates contrast enhancement at the leading edge of demyelinating lesion. MRI, magnetic resonance imaging.
Fig. 2
Fig. 2
Brain MRI at the age of 12 years. (A) T2-weighted image shows demyelinating lesion and cerebral volume loss. (B) T1-weighted image post gadolinium administration demonstrates resolution of contrast enhancement.
See this image and copyright information in PMC

References

    1. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis 1992;15(04):645–664 - PubMed
    1. Raymond GV, Moser AB, Fatemi A X–Linked adrenoleukodystrophy. GeneReviews Available at: https://www.ncbi.nlm.nih.gov/books/NBK1315/. Accessed November 5, 2018
    1. Moser HW, Naidu S, Kumar AJ, Rosenbaum AE. The adrenoleukodystrophies. Crit Rev Neurobiol 1987;3(01):29–88 - PubMed
    1. Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 2014;98:135–142 - PMC - PubMed
    1. Korenke GC, Pouwels PJ, Frahm J, et al. Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. Pediatr Neurol 1996;15(02): 103–107 - PubMed

LinkOut - more resources